Luis Paz-Ares Rodriguez

36PUBLICATIONS
385CO-AUTHORS
Predictive and prognostic markersMolecular targetsSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Nov 11, 2026
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer.

|Nov 06, 2026
PADL1NK-005 study design: a phase III trial of fetrastobart vedotin (Fetra-V) vs docetaxel in patients with previously treated tumor PD-L1-positive NSCLC.

|Oct 16, 2026
Intensive Care in Patients with Solid Tumours: A Practical Framework for Integrated Onco-Critical Care.

|Aug 10, 2026
Rilvegostomig for Metastatic Non-Small Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

|Jun 26, 2026
Early Detriment Analysis of First-Line Nivolumab plus Ipilimumab-Based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer.

|Jun 01, 2026
SEZ6-targeting antibody-drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial.

Pageof 6

Frequent Collaborators

12 joint publications

Enriqueta Felip

7 joint publications

Byoung Chul Cho

5 joint publications

Melissa L Johnson

5 joint publications

James Chih-Hsin Yang